FTC Focus: How Scrutiny Of PBMs And Insulin May Play Out
This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss the FTC's complaint on PBMs' conduct around insulin....To view the full article, register now.
Already a subscriber? Click here to view full article